David A. Sinclair, Ph.D. is a Professor in the Pathology Department at Harvard Medical School, Boston, and is Co-Director of the Glenn Laboratories for Aging Research. He is known for his research into genes and small molecules that control the body’s defenses against disease and aging. He has received numerous academic awards, has authored over 65 scientific publications, and was honored with being one of the “brightest minds under 45″ in 2006. In 2004 he co-founded Sirtris Pharmaceuticals to develop drugs to treat age-associated diseases, which was acquired by GlaxoSmithKline. In 2006, he co-founded Genocea Biosciences, a vaccine discovery company, to prevent diseases in developed and developing countries. Dr. Sinclair’s research has been featured in major print media and has appeared on Nightline, The Charlie Rose Show, 60 minutes, Barbara Walters Special, and Nova. He is currently a Senior Scholar of the Ellison Medical Foundation.